Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 12.52 -5.58% -0.74
FLXN closed down 5.58 percent on Friday, May 17, 2019, on 72 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical FLXN trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength -5.58%
Wide Bands Range Expansion -5.58%
Above Upper BB Strength -5.58%
Gapped Up Strength -5.58%
Overbought Stochastic Strength -5.58%

Older signals for FLXN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Chemistry Pain Organic Compounds Organic Chemistry Osteoarthritis Arthritis Glucocorticoids Skeletal Disorders Organofluorides Tropomyosin Receptor Kinase A
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.1
52 Week Low 9.65
Average Volume 689,228
200-Day Moving Average 15.4403
50-Day Moving Average 11.6586
20-Day Moving Average 11.247
10-Day Moving Average 11.762
Average True Range 0.7546
ADX 24.86
+DI 30.9408
-DI 17.9819
Chandelier Exit (Long, 3 ATRs ) 11.1362
Chandelier Exit (Short, 3 ATRs ) 11.9138
Upper Bollinger Band 13.1407
Lower Bollinger Band 9.3533
Percent B (%b) 0.84
BandWidth 33.674758
MACD Line 0.2931
MACD Signal Line -0.0079
MACD Histogram 0.301
Fundamentals Value
Market Cap 399.45 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -4.03
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.84
Resistance 3 (R3) 13.96 13.65 13.62
Resistance 2 (R2) 13.65 13.31 13.59 13.55
Resistance 1 (R1) 13.08 13.10 12.93 12.96 13.47
Pivot Point 12.77 12.77 12.69 12.71 12.77
Support 1 (S1) 12.20 12.43 12.05 12.08 11.57
Support 2 (S2) 11.89 12.22 11.83 11.49
Support 3 (S3) 11.32 11.89 11.42
Support 4 (S4) 11.20